Anti-elongation factor-1α autoantibody in adult atopic dermatitis patients

International Immunology

Volumn 11, Issue 10, 1999, Pages 1635-1640

  Ohkouchi, Kumiko ^a   Mizutani, Hitoshi ^a   Tanaka, Minoru ^a   Takahashi, Machiko ^a   Nakashima, Kunio ^a   Shimizu, Masayuki ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergen; Allergy; Autoimmunity; Erythematosus; Exanthema

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENTARY DNA; ELONGATION FACTOR; ELONGATION FACTOR 1ALPHA; HYBRID PROTEIN; IMMUNOGLOBULIN G;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNITY; CELL NUCLEUS; CYTOPLASM; DNA LIBRARY; DNA SEQUENCE; FEMALE; HELA CELL; HUMAN; IMMUNOBLOTTING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CLONING, MOLECULAR; DERMATITIS, ATOPIC; DNA, COMPLEMENTARY; FACIAL DERMATOSES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE ELONGATION FACTOR 1;

EID: 0032867881     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.10.1635     Document Type: Article

References (22)

1. Vowles, M., Warin, R. P. and Apley, J. 1955. Infantile eczema: observations on natural history and prognosis. Br. J. Dermatol. 67:53.
2. Vickers, C. F. H. 1980. The natural history of atopic eczema. Acta Dermato-Venereol. 92:s113.
3. Berth-Jones, J., Graham-Brown, R. A., Marks, R., Camp, R. D., English, J. S., Freeman, K., Holden, C. A., Rogers, S. C., Oliwiecki, S., Friedmann, P. S., Lewis-Jones, M. S., Archer, C. B., Adriaans, B., Douglas, W. S. and Allen, B. R. 1997. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br. J. Dermatol. 136:76.
4. Camp, R. D., Reitamo, S., Friedmann, P. S., Ho, V. and Heule, F. 1993. Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993. Br. J. Dermatol. 129:217.
5. Tada, J., Toi, Y., Yoshioka, T., Fujiwara, H. and Arata, J. 1994. Antinuclear antibodies in patients with atopic dermatitis and severe facial lesions. Dermatology 189:38.
6. Taniguchi, Y., Yamakami, A., Sakamoto, T., Nakamura, Y., Okada, H., Tanaka, H., Mizutani, H. and Shimizu, M. 1992. Positive antinuclear antibody in atopic dermatitis. Acta Dermato-Venereol. Suppl. 176:62.
7. Imai, S., Takeuchi, S. and Mashiko, T. 1987. Seasonal changes in the course of atopic eczema. Hautarzt 38:599.
8. Hanifin, J. M. and Rajka, G. 1980. Diagnostic features of atopic dermatitis. Acta Dermato-Venereol. Suppl. 92:44.
9. Reichlin, M. and Harley, J. B. 1997. Antinuclear antibodies. In Wallace, D. J. and Hahn, B. H., eds, Dubois' Lupus Erythematosus, 5th edn, p. 397. Williams & Wilkins, Baltimore, MD.
10. Madsen, H. O., Poulsen, K., Dahl, O., Clark, B. F. and Hjorth, J. P. 1990. Retropseudogenes constitute the major part of the human elongation factor 1 alpha gene family. Nucleic Acids Res. 18:1513.
11. Shiina, N., Gotoh, Y., Kubomura, N., Iwamatsu, A. and Nishida, E. 1994. Microtubule severing by elongation factor 1 alpha. Science 266:282.
12. Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N. and Winchester, R. J. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271.
13. Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:1725.
14. Hollingsworth, P. N., Phil, D., Rummer, S. C. and Dawkins, R. L. 1996. Antinuclear antibodies. In Peter, J. B. and Shoenfeld, Y., eds, Autoantibodies, p. 74. Elsevier Science, Amsterdam.
15. Madsen, H. O., Poulsen, K., Dahl, O., Clark, B. F. and Hjorth, J. P. 1990. Retropseudogenes constitute the major part of the human elongation factor 1 alpha gene family. Nucleic Acids Res. 18:1513.
16. Targoff, I. N. and Hanas, J. 1989. The polymyositis-associated antigen is elongation factor 1α. Arthritis Rheum. 32:81.
17. Pachman, L. M. and Miller, F. W. 1995. Idiopathic inflammatory myopathies: dermatomyositis, polymyositis and related disorders. In Frank, M. M., Austen, K. F., Claman, H. N. and Unanue, E. R., eds, Samter's Immnologic Disease, 5th edn, p. 791. Little, Brown & Co., Boston, MA.
18. Peng, S. L. and Craft, J. E. 1996. Spliceosomal snRNPs autoantibodies: In Peter, J. B. and Shoenfeld, Y., eds, Autoantibodies, p. 774. Elsevier Science, Amsterdam.
19. Reichlin, M. and Scofield, R. L. 1996. SS-A (Ro) autoantibodies. In Peter, J. B. and Shoenfeld, Y., eds, Autoantibodies, p. 783. Elsevier Science, Amsterdam.
20. Picascia, D. D., Rothe, M., Goldberg, N. S. and Roenigk, H., Jr. 1987. Antinuclear antibodies during psoralens plus ultraviolet A (PUVA) therapy - are they worthwhile? J. Am. Acad. Dermatol. 16:574.
21. Wu-Baer, F., Lane, W. S. and Gaynor, R. B. 1996. Identification of a group of cellular cofactors that stimulate the binding of RNA polymerase II and TRP-185 to human immunodeficiency virus 1 TAR RNA. J. Biol. Chem. 271:4201.
22. Schuurman, H. J., Joling, P., van Wichen, D. F., Tobin, D. and van der Putte, S. C. 1993. Epitopes of human immunodeficiency virus regulatory proteins tat, nef and rev are expressed in skin in atopic dermatitis. Int. Arch. Allergy Immunol. 100:107.